Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer.

Casas-Arozamena C, Díaz E, Moiola CP, Alonso-Alconada L, Ferreirós A, Abalo A, Gil CL, Oltra SS, de Santiago J, Cabrera S, Sampayo V, Bouso M, Arias E, Cueva J, Colas E, Vilar A, Gil-Moreno A, Abal M, Moreno-Bueno G, Muinelo-Romay L.

J Clin Med. 2020 Feb 21;9(2). pii: E585. doi: 10.3390/jcm9020585.

2.

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer.

Herrero C, de la Fuente A, Casas-Arozamena C, Sebastian V, Prieto M, Arruebo M, Abalo A, Colás E, Moreno-Bueno G, Gil-Moreno A, Vilar A, Cueva J, Abal M, Muinelo-Romay L.

Cancers (Basel). 2019 Dec 12;11(12). pii: E2000. doi: 10.3390/cancers11122000.

3.

Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer.

Mariscal J, Fernandez-Puente P, Calamia V, Abalo A, Santacana M, Matias-Guiu X, Lopez-Lopez R, Gil-Moreno A, Alonso-Alconada L, Abal M.

J Proteome Res. 2019 Mar 1;18(3):1043-1053. doi: 10.1021/acs.jproteome.8b00750. Epub 2019 Jan 11.

PMID:
30585730
4.

The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.

Franke FC, Müller J, Abal M, Medina ED, Nitsche U, Weidmann H, Chardonnet S, Ninio E, Janssen KP.

Cell Mol Gastroenterol Hepatol. 2018 Sep 11;7(1):33-53. doi: 10.1016/j.jcmgh.2018.08.007. eCollection 2019.

5.

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.

Muinelo-Romay L, Casas-Arozamena C, Abal M.

Int J Mol Sci. 2018 Aug 7;19(8). pii: E2311. doi: 10.3390/ijms19082311. Review.

6.

ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.

Devis L, Martinez-Garcia E, Moiola CP, Quiles MT, Arbos MA, Stirbat TV, Brochard-Wyart F, García Á, Alonso-Alconada L, Abal M, Diaz-Feijoo B, Thomas W, Dufour S, Mancebo G, Alameda F, Reventos J, Gil-Moreno A, Colas E.

Oncotarget. 2018 Mar 30;9(24):16648-16664. doi: 10.18632/oncotarget.24625. eCollection 2018 Mar 30.

7.

Determination of hemodynamic risk for vascular disease in planar artery bifurcations.

Otero-Cacho A, Aymerich M, Flores-Arias MT, Abal M, Álvarez E, Pérez-Muñuzuri V, Muñuzuri AP.

Sci Rep. 2018 Feb 12;8(1):2795. doi: 10.1038/s41598-018-21126-1.

8.

Improving zebrafish embryo xenotransplantation conditions by increasing incubation temperature and establishing a proliferation index with ZFtool.

Cabezas-Sainz P, Guerra-Varela J, Carreira MJ, Mariscal J, Roel M, Rubiolo JA, Sciara AA, Abal M, Botana LM, López R, Sánchez L.

BMC Cancer. 2018 Jan 2;18(1):3. doi: 10.1186/s12885-017-3919-8.

9.

PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health system.

Alonso-Alconada L, Barbazan J, Candamio S, Falco JL, Anton C, Martin-Saborido C, Fuster G, Sampedro M, Grande C, Lado R, Sampietro-Colom L, Crego E, Figueiras S, Leon-Mateos L, Lopez-Lopez R, Abal M.

Clin Transl Oncol. 2018 May;20(5):630-638. doi: 10.1007/s12094-017-1760-9. Epub 2017 Oct 20. Review.

PMID:
29058262
10.

Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients.

León-Mateos L, Casas H, Abalo A, Vieito M, Abreu M, Anido U, Gómez-Tato A, López R, Abal M, Muinelo-Romay L.

Oncotarget. 2017 May 19;8(33):54708-54721. doi: 10.18632/oncotarget.18025. eCollection 2017 Aug 15.

11.

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study.

Insua YV, Cámara J, Vázquez EB, Fernández A, Rivera FV, Silva MJVV, Barbazán J, Muinelo-Romay L, Folgar SC, Abalo A, López-López R, Abal M, Alonso-Alconada L.

Int J Mol Sci. 2017 Jun 13;18(6). pii: E1265. doi: 10.3390/ijms18061265.

12.

Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.

Barbazán J, Alonso-Alconada L, Elkhatib N, Geraldo S, Gurchenkov V, Glentis A, van Niel G, Palmulli R, Fernández B, Viaño P, Garcia-Caballero T, López-López R, Abal M, Vignjevic DM.

Cancer Res. 2017 Jul 1;77(13):3431-3441. doi: 10.1158/0008-5472.CAN-16-1917. Epub 2017 May 23.

13.

Characterizing the contribution of inflammasome-derived exosomes in the activation of the immune response.

Abal M.

Ann Transl Med. 2017 Apr;5(7):172. doi: 10.21037/atm.2017.03.48. No abstract available.

14.

Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.

García-Sanz P, Triviño JC, Mota A, Pérez López M, Colás E, Rojo-Sebastián A, García Á, Gatius S, Ruiz M, Prat J, López-López R, Abal M, Gil-Moreno A, Reventós J, Matias-Guiu X, Moreno-Bueno G.

Int J Cancer. 2017 Apr 1;140(7):1551-1563. doi: 10.1002/ijc.30573. Epub 2017 Feb 2.

15.

Endometrial Carcinoma: Specific Targeted Pathways.

Eritja N, Yeramian A, Chen BJ, Llobet-Navas D, Ortega E, Colas E, Abal M, Dolcet X, Reventos J, Matias-Guiu X.

Adv Exp Med Biol. 2017;943:149-207. Review.

PMID:
27910068
16.

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.

Mariscal J, Alonso-Nocelo M, Muinelo-Romay L, Barbazan J, Vieito M, Abalo A, Gomez-Tato A, Maria de Los Angeles CC, Garcia-Caballero T, Rodriguez C, Brozos E, Baron F, Lopez-Lopez R, Abal M.

Sci Rep. 2016 Nov 30;6:37820. doi: 10.1038/srep37820.

17.

Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.

Devis L, Moiola CP, Masia N, Martinez-Garcia E, Santacana M, Stirbat TV, Brochard-Wyart F, García Á, Alameda F, Cabrera S, Palacios J, Moreno-Bueno G, Abal M, Thomas W, Dufour S, Matias-Guiu X, Santamaria A, Reventos J, Gil-Moreno A, Colas E.

J Pathol. 2017 Mar;241(4):475-487. doi: 10.1002/path.4851. Epub 2017 Jan 23.

PMID:
27873306
18.

EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.

Vila A, Abal M, Muinelo-Romay L, Rodriguez-Abreu C, Rivas J, López-López R, Costa C.

PLoS One. 2016 Oct 6;11(10):e0163705. doi: 10.1371/journal.pone.0163705. eCollection 2016.

19.

Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers.

Mota A, Colás E, García-Sanz P, Campoy I, Rojo-Sebastián A, Gatius S, García Á, Chiva L, Alonso S, Gil-Moreno A, González-Tallada X, Díaz-Feijoo B, Vidal A, Ziober-Malinowska P, Bobiński M, López-López R, Abal M, Reventós J, Matias-Guiu X, Moreno-Bueno G.

Mod Pathol. 2017 Jan;30(1):134-145. doi: 10.1038/modpathol.2016.143. Epub 2016 Sep 2.

20.

Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node.

Alonso-Nocelo M, Abellan-Pose R, Vidal A, Abal M, Csaba N, Alonso MJ, Lopez-Lopez R, de la Fuente M.

J Nanobiotechnology. 2016 Jun 23;14(1):51. doi: 10.1186/s12951-016-0207-8.

21.

Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation.

de la Cruz-Herrera CF, Baz-Martínez M, Lang V, El Motiam A, Barbazán J, Couceiro R, Abal M, Vidal A, Esteban M, Muñoz-Fontela C, Nieto A, Rodríguez MS, Collado M, Rivas C.

Oncogene. 2016 Jun 2;35(22):2873-80. doi: 10.1038/onc.2015.356. Epub 2015 Sep 28.

PMID:
26411363
22.

A laser-based technology for fabricating a soda-lime glass based microfluidic device for circulating tumour cell capture.

Nieto D, Couceiro R, Aymerich M, Lopez-Lopez R, Abal M, Flores-Arias MT.

Colloids Surf B Biointerfaces. 2015 Oct 1;134:363-9. doi: 10.1016/j.colsurfb.2015.07.007. Epub 2015 Jul 11.

PMID:
26218523
23.

M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis.

de la Fuente A, Alonso-Alconada L, Costa C, Cueva J, Garcia-Caballero T, Lopez-Lopez R, Abal M.

J Natl Cancer Inst. 2015 Jul 6;107(9). pii: djv184. doi: 10.1093/jnci/djv184. Print 2015 Sep.

24.

Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling.

Aznar N, Midde KK, Dunkel Y, Lopez-Sanchez I, Pavlova Y, Marivin A, Barbazán J, Murray F, Nitsche U, Janssen KP, Willert K, Goel A, Abal M, Garcia-Marcos M, Ghosh P.

Elife. 2015 Jun 30;4:e07091. doi: 10.7554/eLife.07091.

25.

Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.

Pedrola N, Devis L, Llauradó M, Campoy I, Martinez-Garcia E, Garcia M, Muinelo-Romay L, Alonso-Alconada L, Abal M, Alameda F, Mancebo G, Carreras R, Castellví J, Cabrera S, Gil-Moreno A, Matias-Guiu X, Iovanna JL, Colas E, Reventós J, Ruiz A.

Clin Exp Metastasis. 2015 Jun;32(5):467-78. doi: 10.1007/s10585-015-9720-7. Epub 2015 Apr 30.

PMID:
25924802
26.

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.

Alonso-Alconada L, Muinelo-Romay L, Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J, Wik E, Hapangama D, Coenegrachts L, Cano A, Gil-Moreno A, Chiva L, Cueva J, Vieito M, Ortega E, Mariscal J, Colas E, Castellvi J, Cusido M, Dolcet X, Nijman HW, Bosse T, Green JA, Romano A, Reventos J, Lopez-Lopez R, Salvesen HB, Amant F, Matias-Guiu X, Moreno-Bueno G, Abal M; ENITEC Consortium.

Mol Cancer. 2014 Sep 27;13:223. doi: 10.1186/1476-4598-13-223.

27.

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.

Alonso-Alconada L, Eritja N, Muinelo-Romay L, Barbazan J, Lopez-Lopez R, Matias-Guiu X, Gil-Moreno A, Dolcet X, Abal M.

Carcinogenesis. 2014 Dec;35(12):2679-86. doi: 10.1093/carcin/bgu198. Epub 2014 Sep 18.

PMID:
25233929
28.

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

Alonso-Alconada L, Santacana M, Garcia-Sanz P, Muinelo-Romay L, Colas E, Mirantes C, Monge M, Cueva J, Oliva E, Soslow RA, Lopez MA, Palacios J, Prat J, Valls J, Krakstad C, Salvesen H, Gil-Moreno A, Lopez-Lopez R, Dolcet X, Moreno-Bueno G, Reventos J, Matias-Guiu X, Abal M.

Int J Cancer. 2015 Apr 15;136(8):1863-73. doi: 10.1002/ijc.29213. Epub 2014 Sep 29.

29.

A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.

Barbazán J, Muinelo-Romay L, Vieito M, Candamio S, Díaz-López A, Cano A, Gómez-Tato A, Casares de Cal Mde L, Abal M, López-López R.

Int J Cancer. 2014 Dec 1;135(11):2633-43. doi: 10.1002/ijc.28910. Epub 2014 Apr 29.

30.

Biosensors for the detection of circulating tumour cells.

Costa C, Abal M, López-López R, Muinelo-Romay L.

Sensors (Basel). 2014 Mar 10;14(3):4856-75. doi: 10.3390/s140304856. Review.

31.

The Human Umbilical Cord Tissue-Derived MSC Population UCX(®) Promotes Early Motogenic Effects on Keratinocytes and Fibroblasts and G-CSF-Mediated Mobilization of BM-MSCs When Transplanted In Vivo.

Miranda JP, Filipe E, Fernandes AS, Almeida JM, Martins JP, De la Fuente A, Abal M, Barcia RN, Cruz P, Cruz H, Castro M, Santos JM.

Cell Transplant. 2015;24(5):865-77. doi: 10.3727/096368913X676231. Epub 2013 Dec 30.

PMID:
24480602
32.

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment.

Muinelo-Romay L, Vieito M, Abalo A, Nocelo MA, Barón F, Anido U, Brozos E, Vázquez F, Aguín S, Abal M, López RL.

Cancers (Basel). 2014 Jan 21;6(1):153-65. doi: 10.3390/cancers6010153.

33.

Zoledronic acid as an antimetastatic agent for different human tumor cell lines.

Muinelo-Romay L, Garcia D, Alonso-Alconada L, Vieito M, Carmona M, Martínez N, Aguín S, Abal M, López-López R.

Anticancer Res. 2013 Dec;33(12):5295-300.

PMID:
24324062
34.

Molecular diagnosis of endometrial cancer from uterine aspirates.

Perez-Sanchez C, Colas E, Cabrera S, Falcon O, Sanchez-del-Río A, García E, Fernández-de-Castillo L, Muruzabal JC, Alvarez E, Fiol G, González C, Torrejón R, Moral E, Campos M, Repollés M, Carreras R, Jiménez-López J, Xercavins J, Aibar E, Perdones-Montero A, Lalanne E, Palicio M, Maes T, Rosell-Vives E, Nieto C, Ortega A, Pedrola N, Llauradó M, Rigau M, Doll A, Abal M, Ponce J, Gil-Moreno A, Reventós J.

Int J Cancer. 2013 Nov 15;133(10):2383-91. doi: 10.1002/ijc.28243. Epub 2013 Jun 21.

35.

The EMT signaling pathways in endometrial carcinoma.

Colas E, Pedrola N, Devis L, Ertekin T, Campoy I, Martínez E, Llauradó M, Rigau M, Olivan M, Garcia M, Cabrera S, Gil-Moreno A, Xercavins J, Castellvi J, Garcia A, Ramon y Cajal S, Moreno-Bueno G, Dolcet X, Alameda F, Palacios J, Prat J, Doll A, Matias-Guiu X, Abal M, Reventos J.

Clin Transl Oncol. 2012 Oct;14(10):715-20. doi: 10.1007/s12094-012-0866-3. Epub 2012 Aug 22. Review.

PMID:
22911547
36.

Molecular characterization of circulating tumor cells in human metastatic colorectal cancer.

Barbazán J, Alonso-Alconada L, Muinelo-Romay L, Vieito M, Abalo A, Alonso-Nocelo M, Candamio S, Gallardo E, Fernández B, Abdulkader I, de Los Ángeles Casares M, Gómez-Tato A, López-López R, Abal M.

PLoS One. 2012;7(7):e40476. doi: 10.1371/journal.pone.0040476. Epub 2012 Jul 10.

37.

Endometrial carcinoma: molecular alterations involved in tumor development and progression.

Yeramian A, Moreno-Bueno G, Dolcet X, Catasus L, Abal M, Colas E, Reventos J, Palacios J, Prat J, Matias-Guiu X.

Oncogene. 2013 Jan 24;32(4):403-13. doi: 10.1038/onc.2012.76. Epub 2012 Mar 19. Review.

PMID:
22430211
38.

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer.

Barbazán J, Vieito M, Abalo A, Alonso-Alconada L, Muinelo-Romay L, Alonso-Nocelo M, León L, Candamio S, Gallardo E, Anido U, Doll A, de los Ángeles Casares M, Gómez-Tato A, Abal M, López-López R.

J Cell Mol Med. 2012 Oct;16(10):2342-9. doi: 10.1111/j.1582-4934.2012.01544.x.

39.

Tumor invasion and oxidative stress: biomarkers and therapeutic strategies.

Muinelo-Romay L, Alonso-Alconada L, Alonso-Nocelo M, Barbazan J, Abal M.

Curr Mol Med. 2012 Jul 1;12(6):746-62. Review.

PMID:
22292441
40.

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.

Colas E, Muinelo-Romay L, Alonso-Alconada L, Llaurado M, Monge M, Barbazan J, Gonzalez M, Schoumacher M, Pedrola N, Ertekin T, Devis L, Ruiz A, Castellvi J, Doll A, Gil-Moreno A, Vazquez-Levin M, Lapyckyj L, Lopez-Lopez R, Robine S, Friederich E, Castro M, Reventos J, Vignjevic D, Abal M.

Oncogene. 2012 Nov 8;31(45):4778-88. doi: 10.1038/onc.2011.632. Epub 2012 Jan 23.

PMID:
22266854
41.

Generation and characterization of orthotopic murine models for endometrial cancer.

Cabrera S, Llauradó M, Castellví J, Fernandez Y, Alameda F, Colás E, Ruiz A, Doll A, Schwartz S Jr, Carreras R, Xercavins J, Abal M, Gil-Moreno A, Reventós J.

Clin Exp Metastasis. 2012 Mar;29(3):217-27. doi: 10.1007/s10585-011-9444-2. Epub 2011 Dec 25.

PMID:
22198674
42.

Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease.

Llauradó M, Ruiz A, Majem B, Ertekin T, Colás E, Pedrola N, Devis L, Rigau M, Sequeiros T, Montes M, Garcia M, Cabrera S, Gil-Moreno A, Xercavins J, Castellví J, Garcia A, Ramón y Cajal S, Moreno G, Alameda F, Vázquez-Levin M, Palacios J, Prat J, Doll A, Matías-Guiu X, Abal M, Reventós J.

Mol Cell Endocrinol. 2012 Jul 25;358(2):244-55. doi: 10.1016/j.mce.2011.10.003. Epub 2011 Oct 20. Review.

PMID:
22037169
43.

High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion.

Muinelo-Romay L, Colas E, Barbazan J, Alonso-Alconada L, Alonso-Nocelo M, Bouso M, Curiel T, Cueva J, Anido U, Forteza J, Gil-Moreno A, Reventos J, Lopez-Lopez R, Abal M.

Mol Cancer Ther. 2011 Aug;10(8):1357-66. doi: 10.1158/1535-7163.MCT-10-1019. Epub 2011 May 25.

44.

A three-gene panel on urine increases PSA specificity in the detection of prostate cancer.

Rigau M, Ortega I, Mir MC, Ballesteros C, Garcia M, Llauradó M, Colás E, Pedrola N, Montes M, Sequeiros T, Ertekin T, Majem B, Planas J, Ruiz A, Abal M, Sánchez A, Morote J, Reventós J, Doll A.

Prostate. 2011 Dec;71(16):1736-45. doi: 10.1002/pros.21390. Epub 2011 Apr 25.

PMID:
21520154
45.

ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.

Llauradó M, Abal M, Castellví J, Cabrera S, Gil-Moreno A, Pérez-Benavente A, Colás E, Doll A, Dolcet X, Matias-Guiu X, Vazquez-Levin M, Reventós J, Ruiz A.

Int J Cancer. 2012 Apr 1;130(7):1532-43. doi: 10.1002/ijc.26148. Epub 2011 Aug 12.

46.

Molecular markers of endometrial carcinoma detected in uterine aspirates.

Colas E, Perez C, Cabrera S, Pedrola N, Monge M, Castellvi J, Eyzaguirre F, Gregorio J, Ruiz A, Llaurado M, Rigau M, Garcia M, Ertekin T, Montes M, Lopez-Lopez R, Carreras R, Xercavins J, Ortega A, Maes T, Rosell E, Doll A, Abal M, Reventos J, Gil-Moreno A.

Int J Cancer. 2011 Nov 15;129(10):2435-44. doi: 10.1002/ijc.25901. Epub 2011 Apr 8. Erratum in: Int J Cancer. 2012 Jun 15;130(12):E4.

47.

A transcriptional signature associated with the onset of benign prostate hyperplasia in a canine model.

Gallardo-Arrieta F, Doll A, Rigau M, Mogas T, Juanpere N, García F, Morote J, Nuñez F, Abal M, Lloreta J, Reventós J.

Prostate. 2010 Sep 15;70(13):1402-12. doi: 10.1002/pros.21175.

PMID:
20687213
48.

PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.

Rigau M, Morote J, Mir MC, Ballesteros C, Ortega I, Sanchez A, Colás E, Garcia M, Ruiz A, Abal M, Planas J, Reventós J, Doll A.

Prostate. 2010 Dec 1;70(16):1760-7. doi: 10.1002/pros.21211.

PMID:
20672322
49.

Subtractive proteomic approach to the endometrial carcinoma invasion front.

Monge M, Doll A, Colas E, Gil-Moreno A, Castellvi J, Garcia A, Colome N, Perez-Benavente A, Pedrola N, Lopez-Lopez R, Dolcet X, Ramon y Cajal S, Xercavins J, Matias-Guiu X, Canals F, Reventos J, Abal M.

J Proteome Res. 2009 Oct;8(10):4676-84. doi: 10.1021/pr900390t.

PMID:
19691290
50.

Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.

Monge M, Colas E, Doll A, Gil-Moreno A, Castellvi J, Diaz B, Gonzalez M, Lopez-Lopez R, Xercavins J, Carreras R, Alameda F, Canals F, Gabrielli F, Reventos J, Abal M.

Carcinogenesis. 2009 Aug;30(8):1288-97. doi: 10.1093/carcin/bgp119. Epub 2009 May 14.

PMID:
19443906

Supplemental Content

Support Center